Asklepios BioPharmaceutical Inc. (AskBio) Revenue and Competitors
Estimated Revenue & Valuation
- Asklepios BioPharmaceutical Inc. (AskBio)'s estimated annual revenue is currently $114.6M per year.
- Asklepios BioPharmaceutical Inc. (AskBio)'s estimated revenue per employee is $217,000
- Asklepios BioPharmaceutical Inc. (AskBio)'s total funding is $241.8M.
Employee Data
- Asklepios BioPharmaceutical Inc. (AskBio) has 528 Employees.
- Asklepios BioPharmaceutical Inc. (AskBio) grew their employee count by 60% last year.
Asklepios BioPharmaceutical Inc. (AskBio)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO and Co-Founder | Reveal Email/Phone |
3 | Sr. VP, Therapeutics | Reveal Email/Phone |
4 | VP Global Medical Affairs | Reveal Email/Phone |
5 | VP Manufacturing Science and Technology | Reveal Email/Phone |
6 | VP Translational Medicine | Reveal Email/Phone |
7 | VP, Therapeutic Sector Leader | Reveal Email/Phone |
8 | SVP, Head People and Culture | Reveal Email/Phone |
9 | VP IT | Reveal Email/Phone |
10 | VP, Immunology | Reveal Email/Phone |
Asklepios BioPharmaceutical Inc. (AskBio) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Asklepios BioPharmaceutical Inc. (AskBio)?
Asklepios BioPharmaceutical, Inc. (AskBio) was founded in 2001 by Richard Jude Samulski, PhD and Sheila Mikhail in Chapel Hill, NC to take advantage of the deep gene therapy resources in the Research Triangle Park area. AskBio has since set the standard for gene therapy clinical development including a deep portfolio of intellectual property in gene therapy for multiple diseases and an advanced manufacturing process.
keywords:N/A
$241.8M
Total Funding
528
Number of Employees
$114.6M
Revenue (est)
60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Asklepios BioPharmaceutical Inc. (AskBio) News
She joins Spruce from Asklepios BioPharmaceutical (AskBio), where she served as Senior Vice President of Regulatory Affairs. Prior to AskBio...
RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for the LION-101 gene therapy pr ...
RESEARCH TRIANGLE PARK, N.C., May 25, 2021 /PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced that the U.S. Food & Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for LION- ...
RESEARCH TRIANGLE PARK, N.C., May 6, 2021 /PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that the Company will present abstracts and participate in sessions at the upcoming American Society of Gene & ...
Other Companies in Research Triangle Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $566.7M | 2926 | 20% | N/A |